Letizia Crocetti (L Crocetti)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 23

Top Topics

Molecular Dynamics Simulations

Respiratory Tract

Top Venues

International journal of molecular sciences

Molecules (Basel, Switzerland)

Drug development research

Antioxidants (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Ferrara, Alessandra Toti, Elena Lucarini, Carmen Parisio, Laura Micheli, Clara Ciampi, Francesco Margiotta, Letizia Crocetti, Claudia Vergelli, Maria Paola Giovannoni, Lorenzo Di Cesare Mannelli, Carla Ghelardini
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis. Antioxidants (Basel, Switzerland) 12 (6) (2023)
Valentina Ferrara, Alessandra Toti, Elena Lucarini, Carmen Parisio, Laura Micheli, Clara Ciampi, Francesco Margiotta, Letizia Crocetti, Claudia Vergelli, Maria Paola Giovannoni, Lorenzo Di Cesare Mannelli, Carla Ghelardini
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis. Antioxidants (Basel, Switzerland) 12 (6) (2023)
Rosario Tomarchio, Vincenzo Patamia, Chiara Zagni, Letizia Crocetti, Agostino Cilibrizzi, Giuseppe Floresta, Antonio Rescifina
Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors. Molecules (Basel, Switzerland) 28 (6) (2023)
Giuseppe Floresta, Letizia Crocetti, Renan Rodrigues de Oliveira Silva, Vincenzo Patamia, Francesca Mazzacuva, Yu Chee Sonia Chen, Claudia Vergelli, Agostino Cilibrizzi
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors. Archiv der Pharmazie (2023)
Jian Jin, Francesca Mazzacuva, Letizia Crocetti, Maria Paola Giovannoni, Agostino Cilibrizzi
PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes. International journal of molecular sciences 24 (14) (2023)
Letizia Crocetti, Gabriella Guerrini, Fabrizio Melani, Claudia Vergelli, Maria Paola Giovannoni
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABA A Receptor Subtype. Molecules (Basel, Switzerland) 28 (7) (2023)
Rosario Tomarchio, Vincenzo Patamia, Chiara Zagni, Letizia Crocetti, Agostino Cilibrizzi, Giuseppe Floresta, Antonio Rescifina
Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors. Molecules (Basel, Switzerland) 28 (6) (2023)
Letizia Crocetti, Maria Paola Giovannoni, Gabriella Guerrini, Silvia Lamanna, Fabrizio Melani, Gianluca Bartolucci, Marco Pallecchi, Paola Paoli, Martina Lippi, Junjie Wang, Gerhard Dahl
Design, Synthesis and Pharmacological Evaluation of New Quinoline-Based Panx-1 Channel Blockers. International journal of molecular sciences 24 (3) (2023)
Letizia Crocetti, Maria Paola Giovannoni, Gabriella Guerrini, Silvia Lamanna, Fabrizio Melani, Gianluca Bartolucci, Marco Pallecchi, Paola Paoli, Martina Lippi, Junjie Wang, Gerhard Dahl
Design, Synthesis and Pharmacological Evaluation of New Quinoline-Based Panx-1 Channel Blockers. International journal of molecular sciences 24 (3) (2023)
Letizia Crocetti, Maria Paola Giovannoni, Gabriella Guerrini, Silvia Lamanna, Fabrizio Melani, Gianluca Bartolucci, Marco Pallecchi, Paola Paoli, Martina Lippi, Junjie Wang, Gerhard Dahl
Design, Synthesis and Pharmacological Evaluation of New Quinoline-Based Panx-1 Channel Blockers. International journal of molecular sciences 24 (3) (2023)
Rosario Tomarchio, Vincenzo Patamia, Chiara Zagni, Letizia Crocetti, Agostino Cilibrizzi, Giuseppe Floresta, Antonio Rescifina
Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors. Molecules (Basel, Switzerland) 28 (6) (2023)
Letizia Crocetti, Giuseppe Floresta, Agostino Cilibrizzi, Maria Paola Giovannoni
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022. Molecules (Basel, Switzerland) 27 (15) (2022)
Letizia Crocetti, Giuseppe Floresta, Chiara Zagni, Divya Merugu, Francesca Mazzacuva, Renan Rodrigues de Oliveira Silva, Claudia Vergelli, Maria Paola Giovannoni, Agostino Cilibrizzi
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2 H )-one as Novel Scaffold for FABP4 Inhibition. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Niccolo Cantini, Igor A Schepetkin, Nadezhda V Danilenko, Andrei I Khlebnikov, Letizia Crocetti, Maria Paola Giovannoni, Liliya N Kirpotina, Mark T Quinn
Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity. Molecules (Basel, Switzerland) 27 (12) (2022)
Letizia Crocetti, Gabriella Guerrini, Maria Paola Giovannoni, Fabrizio Melani, Silvia Lamanna, Lorenzo Di Cesare Mannelli, Elena Lucarini, Carla Ghelardini, Junjie Wang, Gerhard Dahl
New Panx-1 Blockers: Synthesis, Biological Evaluation and Molecular Dynamic Studies. International journal of molecular sciences 23 (9) (2022)
Letizia Crocetti, Gabriella Guerrini, Fabrizio Melani, Claudia Vergelli, Maria Paola Mascia, Maria Paola Giovannoni
GABA A Receptor Modulators with a Pyrazolo[1,5-a]quinazoline Core: Synthesis, Molecular Modelling Studies and Electrophysiological Assays. International journal of molecular sciences 23 (21) (2022)
Giuseppe Floresta, Letizia Crocetti, Maria Paola Giovannoni, Pierfrancesco Biagini, Agostino Cilibrizzi
Repurposing strategies on pyridazinone-based series by pharmacophore- and structure-driven screening. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Letizia Crocetti, Claudia Vergelli, Gabriella Guerrini, Maria Paola Giovannoni, Liliya N Kirpotina, Andrei I Khlebnikov, Carla Ghelardini, Lorenzo Di Cesare Mannelli, Elena Lucarini, Igor A Schepetkin, Mark T Quinn
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis. Molecules (Basel, Switzerland) 26 (21) (2021)
Letizia Crocetti, Gabriella Guerrini
GABAA receptor subtype modulators in medicinal chemistry: an updated patent review (2014-present). Expert opinion on therapeutic patents 30 (6) (2020)
Maria P Giovannoni, Niccolò Cantini, Letizia Crocetti, Gabriella Guerrini, Antonella Iacovone, Igor A Schepetkin, Claudia Vergelli, Andrei I Khlebnikov, Mark T Quinn
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase. Drug development research 80 (5) (2019)
Gabriella Guerrini, Claudia Vergelli, Niccolò Cantini, Maria Paola Giovannoni, Simona Daniele, Maria Paola Mascia, Claudia Martini, Letizia Crocetti
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold. International journal of molecular sciences 20 (6) (2019)
Letizia Crocetti, Mark T Quinn, Igor A Schepetkin, Maria Paola Giovannoni
A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications. Expert opinion on therapeutic patents 29 (7) (2019)
Maria Paola Giovannoni, Letizia Crocetti, Niccolò Cantini, Gabriella Guerrini, Claudia Vergelli, Antonella Iacovone, Elisabetta Teodori, Igor A Schepetkin, Mark T Quinn, Samuele Ciattini, Patrizia Rossi, Paola Paoli
New 3-unsubstituted isoxazolones as potent human neutrophil elastase inhibitors: Synthesis and molecular dynamic simulation. Drug development research 81 (3) (2019)